Business magazine Forbes and online ticketing company SeatGeek said on Wednesday they would terminate deals with blank-check firms, as the SPAC boom fizzles out and such transactions draw greater regulatory scrutiny.
Forbes’ publisher had entered into a $630 million deal last year with former Point72 executive Jonathan Lin-led special purpose acquisition company (SPAC) Magnum Opus to help it build consumer-focused products and cut its reliance on media revenue.
Chief Executive Officer Mike Federle on Wednesday said Forbes’ digital transformation had delivered double-digit growth in revenue and core earnings over the past year, which “significantly outperformed the financial targets provided at the start of the SPAC transaction last year”.
SeatGeek said it had terminated its $1.35 billion SPAC deal with RedBall Acquisition Corp (RBAC.N) due to “volatility in the public markets”.
“Expect more (terminated SPAC deals) to come … This is not the environment for dumb or overpriced deals that make no sense. That was 2021,” said Thomas Hayes, managing member at Great Hill Capital Llc in New York
SPAC deals were among the hottest investment trends during the pandemic as early-stage companies looked to go public without the regulatory scrutiny of a traditional listing.
However, the rapid increase in the number of deals has drawn the attention of the Securities and Exchange Commission, which has proposed new rules and additional disclosures from the deal sponsors.
Adverse market conditions and poor share performance of companies such as Grab as well as media outlet BuzzFeed, which has lost nearly a third of its value since going public earlier this year, have also caused the blank-check frenzy to fizzle out.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Athletes Behind NCAA Antitrust Settlement Push for Collective Bargaining Rights
Dec 11, 2024 by
CPI
Big Tech Stocks Surge as Trump Names Ferguson to Lead FTC
Dec 11, 2024 by
CPI
Synopsys Proposes Divestitures to Secure EU Approval for $35 Billion Ansys Deal
Dec 11, 2024 by
CPI
Renowned Antitrust Expert and Former Morgan Lewis Chair John Shenefield Passes Away
Dec 11, 2024 by
CPI
Trump Taps Mark Meador for Federal Trade Commission Post
Dec 11, 2024 by
CPI
Antitrust Mix by CPI
Coopetition in The Pharma Industry: Challenges for Antitrust
Dec 12, 2024 by
Juan Delgado & Lourdes Sosa
Symmetry and the Sixth Force: The Essential Role of Complements
Dec 12, 2024 by
Adam Brandenburger & Barry Nalebuff
ESG Collaborations in Light of European Antitrust Policy and Enforcement Trends
Dec 12, 2024 by
Christian Ritz, Julia Gingelmaier & Kyra Harmes
Antitrust Chronicle® – Co-opetition
Dec 11, 2024 by
CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI